Additional Information
Avandia
If you or a loved one have taken Avandia, please contact us right away for a free legal consultation. Avandia has recently been linked to an increased chance of heart attack. Even if you have taken Avandia and not experienced heart problems, we’d like to talk to you.
About Avandia and Heart Attack Risk
One of the most promising medications to be developed in recent years was Avandia, a drug from Glaxo Smith Kline frequently prescribed to treat diabetes, one of the most prevalent medical issues facing the United States today.
Despite the early praise Avandia received, a research paper published in the Journal of the American Medical Association (JAMA) found that patients taking Avandia had a 42% greater chance of a heart attack. The results, compiled from four separate clinical trials of Avandia lasting at least one year each, confirm earlier studies suggesting increased cardiological risks from taking Avandia.
In contrast, a separate paper also published by JAMA concluded Actos, a rival diabetes treatment from Takeda Pharmaceuticals, appeared to reduce patients' risk of heart attacks. The studies did not compare Avandia with Actos.
In December 2005, GlaxoSmithKline and FDA alerted healthcare professionals to new information regarding the potential of serious and potentially life-threatening side effects of the popular diabetes mellitus type 2 treating drug Avandia. The FDA alert stated:
"FDA informed healthcare professionals of a potential safety issue related to Avandia (rosiglitazone). An on-going analysis of safety data for the treatment of type 2 diabetes mellitus using Avandia showed differing rates of ischemic cardiovascular events including heart attack or heart-related adverse events, some fatal, relative to other drugs used to treat diabetes. The clinical studies reviewed to date vary with respect to their populations, treatment regimens, and length of follow-up. Based on these data, the risk of ischemic cardiovascular events due to Avandia remain unclear. Prescribers should continue to carefully make individualized treatment decisions for patients with diabetes mellitus."
You can read the complete 2007 Safety Summary, including a link to the FDA News Release and Prescribing Information regarding is issue at: http://www.fda.gov/medwatch/safety/2007/safety07.htm#Avandia
The Avandia attorneys at SimmonsCooper have experience in litigating complex medical matters. We have taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs and devices and over the last few years have represented thousands of pharmaceutical clients and recovered verdicts and settlements totaling more than $100 million.*
Contact us today for a free legal consultation.
* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.
News
